Literature DB >> 19154488

Candidaemia: incidence, risk factors, characteristics and outcomes in immunocompetent critically ill patients.

K Z Vardakas1, A Michalopoulos, K G Kiriakidou, E P Siampli, G Samonis, M E Falagas.   

Abstract

A matched case-control study was conducted to determine the risk factors for development of candidaemia in patients requiring intensive-care unit (ICU) treatment for more than 48 h. Patients were matched according to length of ICU stay, age, department of admission, year of admission and sex. Forty-five patients with candidaemia were identified (0.6 cases/1000 patient-days). Candidaemia developed mainly in critically ill patients with multiple organ failure and end-stage disease. Candida colonization and gastrointestinal surgery were independently associated with candidaemia. ICU and total in-hospital mortality were 40% and 66.7%, respectively. Candidaemia-related mortality was 20%. Candidaemia treatment failure was the only variable associated with in-hospital mortality (p 0.008).

Entities:  

Mesh:

Year:  2009        PMID: 19154488     DOI: 10.1111/j.1469-0691.2008.02653.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  16 in total

1.  Epidemiological Trends of Fungemia in Greece with a Focus on Candidemia during the Recent Financial Crisis: a 10-Year Survey in a Tertiary Care Academic Hospital and Review of Literature.

Authors:  Maria Siopi; Aikaterini Tarpatzi; Eleni Kalogeropoulou; Sofia Damianidou; Alexandra Vasilakopoulou; Sophia Vourli; Spyros Pournaras; Joseph Meletiadis
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

Review 2.  Gut Leakage of Fungal-Derived Inflammatory Mediators: Part of a Gut-Liver-Kidney Axis in Bacterial Sepsis.

Authors:  Panomwat Amornphimoltham; Peter S T Yuen; Robert A Star; Asada Leelahavanichkul
Journal:  Dig Dis Sci       Date:  2019-03-13       Impact factor: 3.199

Review 3.  Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.

Authors:  Andrea Cortegiani; Vincenzo Russotto; Alessandra Maggiore; Massimo Attanasio; Alessandro R Naro; Santi Maurizio Raineri; Antonino Giarratano
Journal:  Cochrane Database Syst Rev       Date:  2016-01-16

4.  Comparison of the epidemiology, risk factors, outcome and degree of organ failures of patients with candidemia acquired before or during ICU treatment.

Authors:  Pekka Ylipalosaari; Tero I Ala-Kokko; Juha Karhu; Markku Koskela; Jouko Laurila; Pasi Ohtonen; Hannu Syrjälä
Journal:  Crit Care       Date:  2012-12-12       Impact factor: 9.097

5.  Oral nystatin prophylaxis in surgical/trauma ICU patients: a randomised clinical trial.

Authors:  Mariateresa Giglio; Giuseppina Caggiano; Lidia Dalfino; Nicola Brienza; Ilaria Alicino; Aurelia Sgobio; Antonella Favale; Caterina Coretti; Maria Teresa Montagna; Francesco Bruno; Filomena Puntillo
Journal:  Crit Care       Date:  2012-12-12       Impact factor: 9.097

Review 6.  The effect of diabetes on mortality in critically ill patients: a systematic review and meta-analysis.

Authors:  Sarah E Siegelaar; Maartje Hickmann; Joost B L Hoekstra; Frits Holleman; J Hans DeVries
Journal:  Crit Care       Date:  2011-09-13       Impact factor: 9.097

7.  continuous versus conventional infusion of amphotericin B deoxycholate: a meta-analysis.

Authors:  Matthew E Falagas; Drosos E Karageorgopoulos; Giannoula S Tansarli
Journal:  PLoS One       Date:  2013-10-21       Impact factor: 3.240

8.  An Observational Study on Early Empiric versus Culture-Directed Antifungal Therapy in Critically Ill with Intra-Abdominal Sepsis.

Authors:  Winnie Lee; Yixin Liew; Maciej Piotr Chlebicki; Sharon Ong; Pang Lee; Andrea Kwa
Journal:  Crit Care Res Pract       Date:  2014-05-15

Review 9.  Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?

Authors:  Vasiliki Soulountsi; Theodoros Schizodimos; Serafeim Chrysovalantis Kotoulas
Journal:  Infection       Date:  2021-06-16       Impact factor: 3.553

10.  Factors predicting prolonged empirical antifungal treatment in critically ill patients.

Authors:  Mohamed Zein; Erika Parmentier-Decrucq; Amer Kalaoun; Olivier Bouton; Frédéric Wallyn; Anne Baranzelli; Dia Elmanser; Boualem Sendid; Saad Nseir
Journal:  Ann Clin Microbiol Antimicrob       Date:  2014-03-11       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.